摘要
Retrospective studies have suggested that combination antibiotic therapy for severe bacteremic pneumococcal pneumonia may reduce mortality. We assessed this issue in a prospective, multicenter, international observational study of 844 adult patients with bacteremia due to Streptococcus pneumoniae. The effect of combination antibiotic therapy versus monotherapy on mortality was examined by univariate analyses and by logistic regression models. The 14-day mortality was not significantly different for the two groups. However, among critically ill patients, combination antibiotic therapy was associated with lower 14-day mortality (23.4 versus 55.3%, p = 0.0015). This improvement in survival was independent of country of origin, intensive care unit support, class of antibiotics, or in vitro activity of the antibiotics prescribed. Combination antibiotic therapy improved survival among critically ill patients with bacteremic pneumococcal illness.
原文 | English |
---|---|
頁(從 - 到) | 440-444 |
頁數 | 5 |
期刊 | American Journal of Respiratory and Critical Care Medicine |
卷 | 170 |
發行號 | 4 |
DOIs | |
出版狀態 | Published - 2004 8月 15 |
All Science Journal Classification (ASJC) codes
- 肺和呼吸系統醫學
- 重症監護和重症監護醫學